NASDAQ:ANTX | Cash Flow Statement | AN2 Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$8.19M
2026-03-31-$10.03M-$12.07M$8.29M$37.33M
2025-12-31-$8.67M-$5.24M$7.17M$0.00
2025-09-30-$9.35M
2025-06-30-$6.46M
2025-03-31-$10.65M-$10.62M$9.19M$65,000.00
2024-12-31-$7.52M-$5.27M-$6.88M$0.00
2024-09-30-$12.75M
2024-06-30-$14.44M
2024-03-31-$16.62M-$17.59M$26.29M$349,000.00
2023-12-31-$16.93M-$17.07M$420,000.00-$321,000.00
2023-09-30-$16.71M
2023-06-30-$15.8M
2023-03-31-$15.32M-$11.6M$10.89M$199,000.00
2022-12-31-$11.84M-$7.64M$6.06M$0.00
2022-09-30-$11.34M
2022-06-30-$10.12M
2022-03-31-$7.66M-$6.74M$13.98M$63.19M
2021-12-31-$7.55M-$8.99M$6.25M-$969,000.00
2021-09-30-$6.94M
2021-06-30-$5.01M
2021-03-31-$2.05M-$1.54M$79.74M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$35.17M-$29.83M$28.31M$113,000.00
2024-12-31-$51.32M-$49.26M$54.59M$372,000.00
2023-12-31-$64.73M-$53.29M-$43.28M$84.99M
2022-12-31-$40.96M-$33.46M-$21.77M$70.36M
2021-12-31-$21.54M-$20.48M-$50.02M$78.54M